Clinical Trials Directory

Trials / Terminated

TerminatedNCT04274114

Treatment of Adults With Generalized Anxiety Disorder Using Glutamine

Efficacy of L-glutamine for the Treatment of Generalized Anxiety Disorder: a Randomized Controlled Trial

Status
Terminated
Phase
Phase 2
Study type
Interventional
Enrollment
38 (actual)
Sponsor
Hospital Universitario Dr. Jose E. Gonzalez · Academic / Other
Sex
All
Age
18 Years – 64 Years
Healthy volunteers
Not accepted

Summary

The objective of this randomized clinical trial is to examine the efficacy of L-glutamine for the treatment of generalized anxiety disorder compared versus placebo.

Conditions

Interventions

TypeNameDescription
DRUGL GlutaminePowder
DRUGPlacebosPowder

Timeline

Start date
2019-01-18
Primary completion
2020-05-12
Completion
2020-05-12
First posted
2020-02-18
Last updated
2021-02-11

Locations

1 site across 1 country: Mexico

Source: ClinicalTrials.gov record NCT04274114. Inclusion in this directory is not an endorsement.

Treatment of Adults With Generalized Anxiety Disorder Using Glutamine (NCT04274114) · Clinical Trials Directory